Mirum Pharmaceuticals, Inc. (MIRM)
96.74
+0.44
(+0.45%)
USD |
NASDAQ |
Aug 24, 16:00
96.74
0.00 (0.00%)
After-Hours: 20:00
Mirum Pharmaceuticals Price to Book Value
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| June 29, 2026 | 30.90 |
| June 26, 2026 | 31.10 |
| June 25, 2026 | 29.47 |
| June 24, 2026 | 28.89 |
| June 23, 2026 | 27.91 |
| June 22, 2026 | 27.08 |
| June 18, 2026 | 26.92 |
| June 17, 2026 | 25.64 |
| June 16, 2026 | 25.51 |
| June 15, 2026 | 25.38 |
| June 12, 2026 | 24.96 |
| June 11, 2026 | 25.01 |
| June 10, 2026 | 23.62 |
| June 09, 2026 | 23.99 |
| June 08, 2026 | 23.51 |
| June 05, 2026 | 23.49 |
| June 04, 2026 | 23.24 |
| June 03, 2026 | 23.07 |
| June 02, 2026 | 23.16 |
| June 01, 2026 | 24.20 |
| May 29, 2026 | 25.50 |
| May 28, 2026 | 25.02 |
| May 27, 2026 | 24.45 |
| May 26, 2026 | 24.85 |
| May 22, 2026 | 24.78 |
| Date | Value |
|---|---|
| May 21, 2026 | 25.29 |
| May 20, 2026 | 24.36 |
| May 19, 2026 | 24.03 |
| May 18, 2026 | 23.99 |
| May 15, 2026 | 25.67 |
| May 14, 2026 | 27.99 |
| May 13, 2026 | 27.43 |
| May 12, 2026 | 26.85 |
| May 11, 2026 | 26.68 |
| May 08, 2026 | 26.92 |
| May 07, 2026 | 25.86 |
| May 06, 2026 | 27.66 |
| May 05, 2026 | 26.58 |
| May 04, 2026 | 26.58 |
| May 01, 2026 | 24.25 |
| April 30, 2026 | 24.45 |
| April 29, 2026 | 23.67 |
| April 28, 2026 | 23.62 |
| April 27, 2026 | 23.24 |
| April 24, 2026 | 22.99 |
| April 23, 2026 | 23.10 |
| April 22, 2026 | 23.70 |
| April 21, 2026 | 23.45 |
| April 20, 2026 | 24.05 |
| April 17, 2026 | 24.61 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Incyte Corp. | 4.054 |
| Insmed, Inc. | 35.74 |
| Alnylam Pharmaceuticals, Inc. | 23.31 |
| BioMarin Pharmaceutical, Inc. | 1.991 |
| Ionis Pharmaceuticals, Inc. | 23.36 |
Price to Book Value Related Metrics
| PS Ratio | 9.033 |
| PEG Ratio | -0.0060 |
| Price | 96.74 |
| Earnings Yield | -15.04% |
| Market Cap | 6.265B |
| PEGY Ratio | -0.0060 |